Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Sun

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2012
Optimal dose for stroke thrombolysis in Asians: low dose may have similar safety and efficacy as standard doseC-H Chen, C-Y Hsieh, T-B Lai, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 28, 2024
[Overview of the ten global conferences on health promotion and implications for future work]M C Sun, S Y Liu, W Wei, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|April 28, 2024
[Quantitative HER2 mRNA assay in breast cancer with HER2 immunohistochemistry 0]M C Sun, S F Wu, Y M Cai, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|July 2, 2024
[Clinicopathological features of breast cancer with HER2 low expression: a real-world retrospective study]K M Li, S F Wu, M C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugateRussell J Sanderson, Michelle A Hering, Stephanie F James, et al.
Bioconjugate Chemistry|September 22, 2005
Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfidesMichael M C Sun, Kevin S Beam, Charles G Cerveny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugateKevin J Hamblett, Peter D Senter, Dana F Chace, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2012
Optimal dose for stroke thrombolysis in Asians: low dose may have similar safety and efficacy as standard doseC-H Chen, C-Y Hsieh, T-B Lai, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 28, 2024
[Overview of the ten global conferences on health promotion and implications for future work]M C Sun, S Y Liu, W Wei, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|April 28, 2024
[Quantitative HER2 mRNA assay in breast cancer with HER2 immunohistochemistry 0]M C Sun, S F Wu, Y M Cai, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|July 2, 2024
[Clinicopathological features of breast cancer with HER2 low expression: a real-world retrospective study]K M Li, S F Wu, M C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugateRussell J Sanderson, Michelle A Hering, Stephanie F James, et al.
Bioconjugate Chemistry|September 22, 2005
Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfidesMichael M C Sun, Kevin S Beam, Charles G Cerveny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugateKevin J Hamblett, Peter D Senter, Dana F Chace, et al.
Pageof 2